The CCHRPP Wuxi Medical Research and Certification Center was also unveiled at the event, providing further support for the innovative medical ecosystem spanning everything from R&D to industrialization within I♼ampus. Wuxi Municipal Bureau of Healthcare and Security as well as Management Committee of Wuxi Hi-tech District also signed a strategic framework agreement to establish a medical bidding and procurement workstation in I♼ampus, offering more policy and resource support the incubation of new medicines, medical equipment, and healthcare solutions. These innovative newcomers are engaged across numerous vanguard healthcare fields, including R&D of innovative drugs, gene sequencing, wearable tech, big data, and internet-linked hospitals, pushing the boundaries of innovation throughout the healthcare ecosystem.Īdditionally, the Wuxi Biomedical Industry Association and CEIBS Alumni Healthcare Industry Association signed to settle in I♼ampus, adding to the industrial ecosystem. Through this year's CIIE, I♼ampus continues to welcome domestic and international innovative forces, including US-based high-tech biotech company UST, alongside Bestudy, LinkDoc, Biortus, Liangzhun Industrial Co., Hainan Medical Science and Technology Co., Leantech, CardioCloud, Zeroad, MiDIVI, Ethicall, and Zhenfu. In just one year, I♼ampus has signed up more than 30 leading firms from home and abroad and welcomed seven international strategic partners, all thanks to government-enterprise cooperation and the efforts of other stakeholders." Despite the pandemic, I♼ampus has been able to maintain close ties with domestic and foreign partners through which it has managed to introduce innovative forces into China and empower the growth of its resident companies.Īddressing I♼ampus' presence at the CIIE, Leon Wang, AstraZeneca's executive vice president as well as international and China president, said, "The CIIE provides an excellent platform for empowering bilateral innovation exchange and cooperation between domestic and foreign partners. I♼ampus held its opening ceremony in September 2019 and was announced fully operational in April 2020. The announcement comes as the economy continues to bear the impact caused by COVID-19 and many industries scramble to transform, spawning new business models. I♼ampus itself entered strategic cooperation for medical innovation with Sweden's BioVenture Hub, facilitating further industrial integration and development of healthcare innovation. At the 3rd CIIE, AstraZeneca's booth showcased the latest innovative offerings from multiple resident companies at I♼ampus, including Teddy Lab Services, MiDIVI, LinkDoc, Liangzhun, Omron Healthcare, CHIC Health, Sanomics, UST, Tricog, and HCmed Innovations.įor this year's expo, the Wuxi government, AstraZeneca, Tigermed, CICC, and other companies jointly released the plan of "Wuxi International Health Investment and Innovation Summit," which will accelerate the promotion of the international influence of the Wuxi biomedical industry. It is the second consecutive year for I♼ampus to showcase at the expo. Wuxi International Life Science Innovation Campus (I♼ampus), an innovation incubation platform co-built by the Wuxi Municipal Government, Wuxi Hi-tech District, and AstraZeneca, signed 12 new innovative companies from home and abroad and secured two innovative partnerships with resident companies at the third China International Import Expo (CIIE) in Shanghai on Friday. Representatives of 12 new innovative companies from home and abroad sign agreements with Wuxi International Life Science Innovation Campus at a ceremony held during the third China International Import Expo (CIIE) in Shanghai, Nov.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |